Farnham, United Kingdom

Johannes Frederik Beeslaar

USPTO Granted Patents = 5 

Average Co-Inventor Count = 14.3

ph-index = 2

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Johannes Frederik Beeslaar

Introduction

Johannes Frederik Beeslaar is a notable inventor based in Farnham, GB. He has made significant contributions to the field of immunology, particularly in the development of compositions aimed at eliciting immune responses against various strains of Neisseria meningitidis. With a total of 5 patents to his name, Beeslaar's work is recognized for its potential impact on public health.

Latest Patents

Beeslaar's latest patents focus on compositions that include a factor H binding protein (fHBP) and a non-serogroup B capsular polysaccharide. These compositions are designed to elicit an immune response against both serogroup B strains and non-serogroup B strains of Neisseria meningitidis. The methods described in his patents are directed towards administration in humans, including adults, adolescents, toddlers, and infants.

Career Highlights

Beeslaar is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to collaborate with other experts in the field, enhancing the development of innovative solutions for combating meningococcal diseases.

Collaborations

Some of his notable coworkers include Kathrin Ute Jansen and Annaliesa Sybil Anderson. Their collaborative efforts contribute to the advancement of research and development in immunological compositions.

Conclusion

Johannes Frederik Beeslaar's contributions to the field of immunology through his innovative patents highlight the importance of research in developing effective vaccines and treatments. His work continues to pave the way for advancements in public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…